Vigafyde Solution
Product Images NDC 80789-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Vigafyde (NDC 80789-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alert (Alert)

FDA Label Image

Ndc 80789-003-15 (Carton Label)

Ndc 80789-003-15 (Carton Label)
The packaging label for VIGAFYDE (vigabatrin) Oral Solution, 100 mg/mL, by Upsher-Smith Laboratories, LLC. The label indicates a 150 mL bottle with oral solution, a concentrated formulation alert, dosing instructions to see prescribing information, storage instructions, and pharmacist dispensing guidance. The design includes brand and generic names, strength, NDC, and manufacturer details, with emphasis on dosage accuracy and safety.*
FDA Label Image

Figure A (Figure A)

Figure A (Figure A)
VIGAFYDE 100 mg/mL oral solution bottle is shown with a white child-resistant cap and a white cylindrical bottle. The label does not display product branding or detailed text. Manufactured by Upsher-Smith Laboratories, LLC.*
FDA Label Image

Figure B (Figure B)

Figure B (Figure B)
An illustration labeled Figure B showing an oral syringe and a bottle adapter. The syringe parts labeled include tip, barrel, dose markings, plunger stopper, and plunger. The bottle adapter is labeled with top and ribbed end.*
FDA Label Image

Figure C (Figure C)

Figure C (Figure C)
Illustration labeled 'Figure C' showing two hands assembling an oral syringe and a bottle adapter. The upper hand holds the oral syringe, while the lower hand holds the bottle adapter. An arrow between them indicates the connection of the syringe to the adapter for medication administration.*
FDA Label Image

Figure D (Figure D)

Figure D (Figure D)
An instructional illustration showing two hands opening a child-resistant white plastic bottle. One hand holds the bottle while the other presses down on the cap and turns it counterclockwise to open.*
FDA Label Image

Figure E (Figure E)

Figure E (Figure E)
An illustration showing the open neck of a plastic bottle with an inner foil seal covering the opening. The label indicates the part as 'Inner seal' and the figure is captioned as 'Figure E'.*
FDA Label Image

Figure F (Figure F)

Figure F (Figure F)
Figure F shows a three-part instructional diagram illustrating assembly of a bottle adapter onto the neck of a bottle, including a close-up view of the assembled bottle and adapter. The images display steps for properly placing the bottle adapter onto the bottle for the oral solution product.*
FDA Label Image

Figure G (Figure G)

Figure G (Figure G)
VIGAFYDE oral solution bottle label showing storage instructions including 'KEEP OUT OF REACH OF CHILDREN' and a section to record the date of first opening. The bottle is white with a white cap and a printed label on the side.*
FDA Label Image

Figure H (Figure H)

Figure H (Figure H)
An instructional illustration showing a hand holding a syringe with the plunger pulled to the 6 mL mark. The image is labeled 'Figure H' with an arrow pointing to the top of the plunger marked as 'End of plunger position.' This diagram is likely part of usage instructions for the oral solution of VIGAFYDE (vigabatrin).*
FDA Label Image

Figure I (Figure I)

Figure I (Figure I)
An instructional diagram showing hands using a syringe to withdraw medication from a bottle labeled with a bottle adapter. The syringe is being inserted downward into the bottle. The components labeled are syringe, bottle adapter, and bottle.*
FDA Label Image

Figure J (Figure J)

Figure J (Figure J)
An instructional illustration showing a person holding a bottle of liquid medication upside down and using a syringe to measure a dose. The inset highlights the correct fill level on the syringe, indicated by a black arrow. Labeled as Figure J, this image demonstrates proper technique for drawing oral solution dosages.*
FDA Label Image

Figure K (Figure K)

Figure K (Figure K)
An instructional illustration showing proper technique for filling a syringe from a bottle. The image includes a photograph of hands drawing liquid from a white bottle into a syringe and a diagram labeled Figure K comparing two syringes: one incorrectly filled with air bubbles marked 'NO', and one correctly filled without air bubbles marked 'YES'.*
FDA Label Image

Figure L (Figure L)

Figure L (Figure L)
Instructional illustration showing a hand removing a syringe from a bottle, indicating the use of an oral dosing syringe with the VIGAFYDE vigabatrin 100 mg/mL solution oral medication bottle for measured administration.*
FDA Label Image

Figure M (Figure M)

Figure M (Figure M)
Black and white illustration showing a young child receiving an oral dose from a syringe held by an adult hand. The image depicts the administration of oral medication to a child, emphasizing the use of a syringe for dosing.*
FDA Label Image

Figure N (Figure N)

Figure N (Figure N)
An instructional black and white illustration showing two hands holding a white plastic bottle. One hand grips the bottle while the other hand twists the child-resistant cap in a counterclockwise direction to open it, indicated by arrows around the cap. The image is labeled 'Figure N.'*
FDA Label Image

All People Who Take Vigafyde (Med Guide Box)

All People Who Take Vigafyde (Med Guide Box)
A text panel addressing caregivers of babies taking VIGAFYDE oral solution. It warns about the risk of permanent vision loss associated with any amount of VIGAFYDE, noting that the risk may increase with daily and prolonged use. It also states that the timing of potential vision loss cannot be predicted and may occur during or after treatment.*
FDA Label Image

Structural Formula For Vigabatrin (Vigabatrin Structure)

Structural Formula For Vigabatrin (Vigabatrin Structure)
Chemical structure diagram of vigabatrin, the active ingredient in VIGAFYDE oral solution 100 mg/mL by Upsher-Smith Laboratories, LLC. The diagram shows the arrangement of atoms and bonds typical for vigabatrin's molecular structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.